Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 1
2006 3
2007 2
2008 1
2009 1
2010 2
2011 3
2012 5
2013 3
2014 4
2015 1
2016 3
2017 4
2018 2
2019 2
2020 2
2021 5
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.
Goto Y, Kenmotsu H, Tamiya M, Murakami S, Kurata T, Yanagitani N, Taniguchi H, Kuyama S, Shimizu J, Yokoyama T, Shimada N, Maeda T, Tamiya A, Uchiyama A, Imaizumi K, Takahama T, Kato T, Hayashi H, Shiraiwa N, Toyoizumi S, Kikkawa H, Thomaidou D, Nishio M. Goto Y, et al. Among authors: shimada n. JTO Clin Res Rep. 2023 Mar 24;4(5):100508. doi: 10.1016/j.jtocrr.2023.100508. eCollection 2023 May. JTO Clin Res Rep. 2023. PMID: 37250506 Free PMC article.
A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1.
Wirawan A, Tajima K, Takahashi F, Mitsuishi Y, Winardi W, Hidayat M, Hayakawa D, Matsumoto N, Izumi K, Asao T, Ko R, Shimada N, Takamochi K, Suzuki K, Abe M, Hino O, Sekido Y, Takahashi K. Wirawan A, et al. Among authors: shimada n. Mol Cancer Res. 2022 Jan;20(1):127-138. doi: 10.1158/1541-7786.MCR-21-0230. Epub 2021 Sep 30. Mol Cancer Res. 2022. PMID: 34593606
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway.
Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I, Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa SI, Takahashi K. Kato M, et al. Among authors: shimada n. Drug Des Devel Ther. 2020 Oct 29;14:4593-4603. doi: 10.2147/DDDT.S264715. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33149556 Free PMC article.
Malignant Pleural Mesothelioma with Bone Marrow Metastases.
Ihara H, Harada N, Shimada N, Kanamori K, Hayashi T, Uekusa T, Takahashi K. Ihara H, et al. Among authors: shimada n. Intern Med. 2018 Sep 1;57(17):2541-2545. doi: 10.2169/internalmedicine.9246-17. Epub 2018 Mar 30. Intern Med. 2018. PMID: 29607973 Free PMC article.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
Kurokawa K, Mitsuishi Y, Shimada N, Kawakami Y, Miura K, Miyawaki T, Asao T, Ko R, Shukuya T, Shibayama R, Nojiri S, Takahashi K. Kurokawa K, et al. Among authors: shimada n. BMC Cancer. 2022 Oct 6;22(1):1047. doi: 10.1186/s12885-022-10133-1. BMC Cancer. 2022. PMID: 36203123 Free PMC article.
49 results